“Electrocardiographic and Biochemical Adverse Effects of Meglumine Antimoniate (MA) During Treatment of Syrian Cutaneous Leishmaniasis Patients”. 2016. Journal of Pakistan Association of Dermatologists 23 (4): 412-17. https://doi.org/10.66344/jpad.v23i4.289.